🇺🇸 FDA
Patent

US 11919896

[1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and use thereof

granted A61KA61K31/437A61P

Quick answer

US patent 11919896 ([1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and use thereof) held by ZHUHAI UNITED LABORATORIES CO., LTD. expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ZHUHAI UNITED LABORATORIES CO., LTD.
Grant date
Tue Mar 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/437, A61P, A61P19/02